Answers are grounded in this paper and cite their sources.
Fabry disease is a rare genetic lysosomal storage disorder characterized by a deficiency of the enzyme alpha-galactosidase A. The recent availability of enzyme-replacement therapy with agalsidase alfa offers specific treatment for this serious, progressive condition.
No takes yet. Share an insight, caveat, or question.
Atul Mehta (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: